Jasper Therapeutics is trading 7.56% down at $0.66 after no clear company-specific announcement was identified for September 8, 2026.
- The latest readily identifiable corporate developments were earlier reports on second-quarter results and the Kira acquisition, not fresh overnight news.
- Broader markets are mixed to lower, but the provided index moves remain insufficient to clearly attribute the decline to overall market sentiment.